OGI - OrganiGram Holdings Inc.
Chart Events
Fast Stochastic
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 1.8000 |
| Open | 1.7900 |
| Bid | 0.0000 x 27000 |
| Ask | 0.0000 x 21500 |
| Day's Range | 1.7600 - 1.9200 |
| 52 Week Range | 1.0900 - 7.6500 |
| Volume | 10,657,179 |
| Avg. Volume | 4,873,639 |
| Market Cap | 308.349M |
| Beta (5Y Monthly) | 3.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
- Zacks
Do Options Traders Know Something About Organigram (OGI) Stock We Don't?
Investors need to pay close attention to Organigram (OGI) stock based on the movements in the options market lately.
- Motley Fool
Why Tilray and OrganiGram Holdings Got Slammed on Friday
A pair of marijuana stocks, Tilray (NASDAQ: TLRY) and OrganiGram Holdings (NASDAQ: OGI), both dropped notably in price on Friday (by 5.2% and 7%, respectively). The culprit seems to be another weed title, Canopy Growth (NYSE: CGC), which earlier in the day published an awful quarterly earnings release. Canopy Growth is a leading company in the sector.
- Business Wire
Organigram Successfully Completes Amendment to Credit Facilities with Bank of Montreal
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (collectively, the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that the Company has amended its credit agreement dated May 31, 2019, with Bank of Montreal ("BMO") as lead arranger and agent as well as a syndicate including three other lenders (the "Credit Agreement Amendment"). The Credit Agreement Amendment modifies certain terms of the $115 million term loan (the "Term Loan") and $25 million revolving credit facility (the "Revolver", and together with the Term Loan, the "Facilities").
- Motley Fool
Why Organigram Stock Surged Today
Shares of Organigram Holdings (NASDAQ: OGI) were flying on Thursday after the company said it was rolling out its "cannabis 2.0" products to its medical marijuana customers. As of 3:27 p.m. EDT, Organigram's stock was up more than 12%. Cannabis 2.0 is a term used to describe second-generation marijuana products such as edibles and beverages, as opposed to cannabis 1.0 products like dried flower.
- Motley Fool
OrganiGram Releases Cannabis 2.0 Products To Medical Users
Vapes and chocolate edibles are among the new cannabis products the company is rolling out to medical marijuana consumers.
- Business Wire
Organigram Rolls out Cannabis 2.0 Products to Medical Consumers
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce that as of May 19th, 2020, the Company has extended its medical cannabis offering to include products from its cannabis 2.0 adult-use recreational portfolio.
- Motley Fool
Got $3,000? These 5 Beaten-Down Stocks Are Begging to Be Bought
No matter how dire things may have appeared in previous bear markets, bull-market rallies eventually erase all evidence of downward moves in the stock market. Also keep in mind that you don't have to be rich to generate a handsome return from the stock market. With the exception of the oil and gas industry, there's probably not a harder-hit industry lately than bank stocks.
- MarketWatch
Aurora Cannabis makes its long-awaited push into the U.S. with Reliva CBD acquisition
Over a year after Aurora Cannabis Inc. executives started publicly talking about making a push into the U.S. market, the company has made its move: the $40 million all-stock purchase of a cannabidiol maker called Reliva.
- Motley Fool
Why Aurora Cannabis Stock Is Falling Today
Shares of Aurora Cannabis (NYSE: ACB) sank on Wednesday after analysts raised concerns that the popular marijuana stock's price gains may have come too far, too fast. As of 3 p.m. EDT, Aurora's stock was down more than 12%. Aurora's shares surged as much as 180% following the cannabis producer's better-than-expected third-quarter sales results on May 14.
- MarketWatch
Aurora Cannabis stock's gains show investors rewarding revenue and ignoring losses: Raymond James
Raymond James analysts said Aurora Cannabis Inc.'s strong stock gains following its recent earnings look overdone compared with the subdued response to stronger numbers from Organigram Inc. and Village Farms International Inc. . In a note looking at the three companies and their businesses, analysts Rahul Sarugaser and Michael Freeman said the market rewarded Aurora's better-than-expected revenue and overlooked its negative EBITDA. "You gotta be kidding me," the analysts wrote in a note to clients. Aurora's shares have gained 77% in the month to date. "As one of our observant colleagues pointed out: ACB's stock gained in value equivalent to twice that of OGI's entire market cap {about $250 million)-- or thrice that of Village Farms' market cap (@178 million)--after reporting a net loss equivalent to about 50% of OGI's market cap, or 75% of VFF's. Let that sink in," the analysts wrote. Organigram and Village Farms are well operated companies that consistently report positive EBITDA and are capturing market share, said the note. Aurora shares were down 4.5% premarket and are down 43% in the year to date, while the Cannabis ETF has fallen 24% and the S&P 500 has fallen 10%.
- Motley Fool
4 Signs the Cannabis Industry Is Still Ultra-High-Risk
If you're looking to invest in the cannabis industry, you have to be prepared to take on some significant risks. The industry's been struggling during the past year, and a turnaround is not necessarily imminent. This year is already setting up to be a challenging one for many pot stocks, and investors should be careful not to be lured in by low prices.
- Zacks
Organigram (OGI) Catches Eye: Stock Jumps 11.7%
Organigram (OGI) saw a big move last session, as its shares jumped nearly 12% on the day, amid huge volumes.
- Motley Fool
Why Canopy Growth, Cronos Group, and OrganiGram Soared Today
Shares of several top Canadian cannabis producers soared today after one of their peers, Aurora Cannabis (NYSE: ACB), reported better-than-expected fiscal 2020 third-quarter revenue growth after the market closed on Thursday. Canopy Growth (NYSE: CGC) stock was up 13.4% as of 3:38 p.m. EDT on Friday, while shares of Cronos Group (NASDAQ: CRON) and OrganiGram Holdings (NASDAQ: OGI) were up 10.3% and 13.5%, respectively. Investors now appear to be increasingly optimistic that the rest of the Canadian cannabis industry could also enjoy a turn for the better after a challenging period following Aurora's surprisingly positive results.
- Motley Fool
OrganiGram Holdings Starts Bringing Employees Back to Work
Around 50 workers will return to the company's New Brunswick headquarters in the opening phase of the plan.
- MarketWatch
Organigram to recall about 50 employees at Moncton, New Brunswick campus in Phase 1 of reopening
Organigram Holdings Inc. said Thursday it is recalling abut 50 employees at its Moncton, New Brunswick campus in the first phase of reopening its cannabis business. "These employees will fill core roles across various departments that have been deemed highest priority by the Organigram leadership team in this initial phase," the Canadian company said in a statement. "Subsequent phases of this plan will be dependent upon public health and safety guidelines and the evolving needs of Organigram's business." Safety measures, including enhanced cleaning and hand sanitizing and social-distancing, will be implemented. U.S.-listed shares were not yet active premarket, but have fallen 52% in the year to date, while the ETFMG Alternative Harvest ETF has fallen 36% and the S&P 500 has fallen 13%.
- Business Wire
Organigram announces first phase of return-to-work strategy
As it continues to monitor and assess the implications of the COVID-19 pandemic, Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, has announced the first phase of its return-to-work strategy. The Company has begun to implement a staggered return-to-work plan effective May 13, 2020.
- Motley Fool
These Pot Stocks May Need to Enact a Reverse Split
Marijuana stocks have plunged so severely that they may need to take drastic measures to avoid being delisted.
- Motley Fool
Court Partially Overturns Class-Action Lawsuit Against OrganiGram Holdings
The legal action against the cannabis company will continue, but its scope has been considerably reduced.
- Business Wire
Court Significantly Reduces Scope of Class Action
MONCTON, New Brunswick--(BUSINESS WIRE)--The Nova Scotia Court of Appeal has partially overturned the certification of a class action (the “Class Action”) against Organigram Inc. (the "Company" or "Organigram") and its parent company Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis in Canada, on April 30, 2020 thereby significantly reducing the scope of the claim against the Company.
- Motley Fool
I Still Have Faith in OrganiGram!
Even after its disastrous second-quarter results and subsequent price drop, I'm sold on this cannabis company's COVID-19 strategies and its approach to cannabis 2.0.
- Motley Fool
Better Buy: OrganiGram Holdings vs. Canopy Growth
Both of these stocks are down more than 60% in the past year, but which one is more likely to bounce back?
- Business Wire
Consumer Research Drives Enhancements to Organigram Adult Recreational Commercial Portfolio
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to provide an update related to the Company’s current and anticipated releases of new adult use recreational cannabis products.
- MarketWatch
Cannabis producer Organigram to raise $35 million through market equity sales
Canada-based marijuana producer Organigram Holdings Inc. said Wednesday that it was raising up to C$49 million ($34.5 million) by selling shares in small batches at market prices. U.S.-traded shares of Organigram fell 1.9% in early afternoon trading. The exact amount and timing of the equity sales, known as an at-the-market program, is up to Organigram executives and will be effective until close to the end of 2021.
- Business Wire
Organigram Holdings Inc. Announces At-The-Market Equity Program
Organigram Holdings Inc. ("Organigram" or the "Corporation") (TSX:OGI) (NASDAQ:OGI) announced today that it has established an at-the-market equity program (the "ATM Program") that allows the Corporation to issue up to C$49,000,000 (or its U.S. dollar equivalent) of common shares ("Common Shares") from treasury to the public from time to time, at the Corporation’s discretion. Any Common Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the "TSX"), the NASDAQ Global Select Market (the "NASDAQ") or any other marketplace on which the Common Shares are listed, quoted or otherwise traded, at the prevailing market price at the time of sale.
- MarketWatch
As cannabis industry stays largely quiet on coronavirus, this CEO has been sounding the alarm
As the COVID-19 pandemic ravaged the globe, Organigram Holdings Inc. was one of the first cannabis companies to begin to warn investors about the impacts on its business and the industry.
